Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

a-closer-look-at-5-analyst-recommendations-for-stoke-therapeutics

A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics

Jun 28, 2024

Ratings for Stoke Therapeutics (NASDAQ:STOK) were provided by 5 analysts in the past three months, showcasing a mix…

Read more
a-closer-look-at-5-analyst-recommendations-for-chargepoint-hldgs

A Closer Look at 5 Analyst Recommendations For ChargePoint Hldgs

Jun 28, 2024

5 analysts have shared their evaluations of ChargePoint Hldgs (NYSE:CHPT) during the recent three months, expressing a mix…

Read more
a-closer-look-at-9-analyst-recommendations-for-cg-oncology

A Closer Look at 9 Analyst Recommendations For CG Oncology

Jun 28, 2024

9 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a…

Read more
peeling-back-the-layers:-exploring-ameriprise-finl-through-analyst-insights

Peeling Back The Layers: Exploring Ameriprise Finl Through Analyst Insights

Jun 28, 2024

Across the recent three months, 7 analysts have shared their insights on Ameriprise Finl (NYSE:AMP), expressing a variety…

Read more
is-tilray’s-$2b-valuation-just-the-beginning?-analyst-sees-$10b-market-opportunity,-initiates-coverage-–-anheuser-busch-inbev-(nyse:bud),-tilray-brands-(nasdaq:tlry)

Is Tilray’s $2B Valuation Just The Beginning? Analyst Sees $10B Market Opportunity, Initiates Coverage – Anheuser-Busch InBev (NYSE:BUD), Tilray Brands (NASDAQ:TLRY)

Jun 28, 2024

With a $2 billion valuation, Tilray Brands TLRY ranks as the largest cannabis company outside the U.S., leading…

Read more
analyst-expectations-for-merit-medical-systems’s-future

Analyst Expectations For Merit Medical Systems’s Future

Jun 28, 2024

Merit Medical Systems (NASDAQ:MMSI) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints…

Read more
a-closer-look-at-4-analyst-recommendations-for-runway-gwth-fin

A Closer Look at 4 Analyst Recommendations For Runway Gwth Fin

Jun 28, 2024

Runway Gwth Fin (NASDAQ:RWAY) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints…

Read more
decoding-7-analyst-evaluations-for-agco

Decoding 7 Analyst Evaluations For AGCO

Jun 28, 2024

AGCO (NYSE:AGCO) has been analyzed by 7 analysts in the last three months, revealing a diverse range of…

Read more
peeling-back-the-layers:-exploring-synchrony-finl-through-analyst-insights

Peeling Back The Layers: Exploring Synchrony Finl Through Analyst Insights

Jun 28, 2024

13 analysts have expressed a variety of opinions on Synchrony Finl (NYSE:SYF) over the past quarter, offering a…

Read more
in-depth-examination-of-13-analyst-recommendations-for-parker-hannifin

In-Depth Examination Of 13 Analyst Recommendations For Parker Hannifin

Jun 28, 2024

Analysts’ ratings for Parker Hannifin (NYSE:PH) over the last quarter vary from bullish to bearish, as provided by…

Read more
critical-insights-from-surgery-partners-analyst-ratings:-what-you-need-to-know

Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know

Jun 28, 2024

In the latest quarter, 4 analysts provided ratings for Surgery Partners (NASDAQ:SGRY), showcasing a mix of bullish and…

Read more
women’s-health-focused-hologic-has-significant-capacity-for-expansion-via-m&a,-bullish-analyst-says

Women’s Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says

Jun 28, 2024

Stephens initiated coverage on Hologic Inc HOLX, citing it as a major player in women’s health, known for…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 317
  6. 318
  7. 319
  8. 320
  9. 321
  10. 322
  11. 323
  12. ...
  13. 379
  14. »

Posts pagination

Newer posts Page 1 … Page 320 … Page 379 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.